Humana has refiled its lawsuit against the federal government over its Medicare Advantage ratings, with billions of dollars ...

Sarepta will halt all shipments of Elevidys, its drug for Duchenne muscular dystrophy patients, by Tuesday evening.

Sanofi is buying Vicebio for more than $1 billion, picking up an experimental vaccine targeting RSV and another respiratory bug.

The crisis over Sarepta Therapeutics' Duchenne therapy offers a valuable lesson: Listening to critics, and responding with ...

CASP, the protein structure prediction contest that launched DeepMind’s Alphafold to international fame and a Nobel Prize, ...

WASHINGTON — President Trump’s major domestic policy law will result in nearly 10 million more people going without health ...

The number of basic science papers published by NIH grant recipients has been falling since 2013, when the agency’s budget ...

AstraZeneca announced that it will invest $50 billion in the U.S. by 2030, including a multi-billion-dollar manufacturing ...

The Food and Drug Administration on Monday named George Tidmarsh, a longtime biotech executive who has a background in ...

Alkermes’ investigational drug helped people with a type of narcolepsy stay awake during the day in a mid-stage trial.

You know you’re going to die, right?” When Joy Lisi Rankin’s mother decided not to treat her breast cancer, doctors were ...

University of Minnesota president Rebecca Cunningham is drawing on her experience as an emergency physician in this ...